• Home
• Mission
• Investigators
• Transgenic Mouse Facility
• Real-time PCR Core Facility
• Human Tumor Bank Core Facility
• Career Opportunities
• Funding Opportunities
• Graduate Training in Cancer
  – Cancer Cell Biology Track
  – SCCCB Predoctoral Fellowship
  – Cancer Center Training Grant
• Seminars
• In the News
• Related Links
• Site Index
• Software - Molecular Biology Tools
• UTMB Cancer Center
• UTMB Home Page

Faculty Investigators

Xiaodong Cheng, Ph.D.
The major research focus in our laboratory is function and regulation of protein kinases and small GTPases and their roles in cancers. We are also conducting study of the molecular mechanism of ovarian cell transformation and tumorgenesis using a genetically defined ovarian cancer model and functional proteomics approaches.

Dai Chung, M.D.
Our ongoing projects include (1) characterizing expression of GRP and GRP-R in various clinical stages of neuroblastomas, (2) determining mechanisms involved in the regulation of GRP-R gene and protein expression, and (3) identifying the role of phosphatidylinositol 3-kinase in GRP-induced proliferation of neuroblastomas.

Jianli Dong, M.D., Ph.D.
RAS/BRAF/MEK/ERK and p16/CDK/RB signaling pathways in cancer biology and Molecular Diagnostics.

Cornelis Elferink, Ph.D.
The long-term research interest in the laboratory is to understand precisely how AhR signaling regulates cell proliferation and apoptosis, and by inference, identify the molecular basis for dioxin-induced toxicity.

Lisa Elferink, Ph.D.
Our research program focuses on understanding the molecular and cellular mechanisms linking membrane trafficking with receptor-signaling. Our goal is to identify novel targets for drug development aimed at treating human diseases involving aberrant receptor signaling in vivo.

Mark R. Emmett, Ph.D.
Current research specializes in identification of novel therapeutic targets and biomarkers in oncology (esp. neuro-oncology).

Miriam Falzon, Ph.D.
Cancer Pharmacology

Mark R. Hellmich, Ph.D.
My major research interest is in the elucidation of signaling pathways regulated by heptahelical
G-protein linked peptide hormone receptors of gastrointestinal tracts, specifically those pathways coupled to the bombesin and gastrin family of receptors.

Stanley M. Lemon, M.D.
Hepatitis A and C, infectious diseases, molecular virology, vaccine development.

Suimin Qiu, M.D., Ph.D.

Vicente Resto, M.D., Ph.D.
Tumors that spread from their original sites to lymph nodes are often more aggressive and least responsive to therapy. Dr. Resto is investigating how head and neck tumors metastasize to lymph nodes. He will focus on identifying glycoproteins on the surface of tumor cells that interact with proteins on lymphocytes (cells found in the lymph nodes), and then determine whether expression of these glycoproteins correlates with lymph node metastasis and clinical outcomes in patients.

Sarita K. Sastry, Ph.D.
My lab studies the role of protein tyrosine phosphatase in controlling cell migration. My long-term goal is to understand their function and regulation during tumor cell invasion and tumor angiogenesis.

Maki Wakamiya, Ph.D.
Transgenic Mouse Core Facility Director.

This site is published by John Helms for the Sealy Center for Cancer Cell Biology.
Copyright © 2003 The University of Texas Medical Branch. Please review our Privacy Policy and Internet Guidelines.
Last reviewed: November 5, 2008.